- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Conexeu Sciences Inc.: Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU" | 334 | Newsfile | Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, announced it has officially... ► Artikel lesen | |
| Di | Conexeu Sciences Inc.: Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants | 348 | Newsfile | Conexeu's B.R.E.A.S.T. was developed using the Company's proprietary CXU regenerative tissue platform to support gradual tissue remodelingDesigned as a resorbable, bioregenerative tissue matrix... ► Artikel lesen | |
| 14.05. | Conexeu Sciences Inc.: Conexeu Sciences Unveils Defining Commitment: Architecting Bioregeneration | 351 | Newsfile | Reno, Nevada--(Newsfile Corp. - May 14, 2026) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a medical device company advancing regenerative medicine through its patented bioregenerative extracellular... ► Artikel lesen | |
| 12.05. | Medical device developer Conexeu Sciences set to direct list on the Nasdaq on May 21 | 1 | Renaissance Capital | ||
| 11.05. | Conexeu Sciences Inc. - 8-A12B, Registration of securities | - | SEC Filings | ||
| CONEXEU SCIENCES Aktie jetzt für 0€ handeln | |||||
| 17.04. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 06.04. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 26.03. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 02.03. | Conexeu Sciences Inc.: Conexeu Sciences Appoints Jean-Romain (JR) Falconnet as Head of Business Development & Licensing | 736 | Newsfile | Reno, Nevada--(Newsfile Corp. - March 2, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular... ► Artikel lesen | |
| 09.02. | Conexeu Sciences Inc.: Conexeu Sciences Appoints Sonia Thomas as Head of Strategy & Transformation to Accelerate Enterprise Growth and Execution Excellence | 952 | Newsfile | Reno, Nevada--(Newsfile Corp. - February 9, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company") a biotechnology innovator redefining regenerative medicine through a next-generation extracellular... ► Artikel lesen | |
| 03.02. | Conexeu Sciences Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 28.11.25 | Conexeu Sciences Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 20.11.25 | Conexeu Sciences Inc.: Conexeu Sciences Signals a Major Breakthrough in 'Personalized Human Tissue Creation' | 203 | Newsfile | Reno, Nevada--(Newsfile Corp. - November 20, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation collagen-based... ► Artikel lesen | |
| 05.11.25 | Conexeu Sciences Inc. Expands Board of Directors with the Appointments of Dr. Aaron Farberg and Dr. Sebastian Purcell | 228 | Newsfile | Reno, Nevada--(Newsfile Corp. - November 5, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation collagen-based... ► Artikel lesen | |
| 03.11.25 | Conexeu Sciences Inc.: Conexeu Sciences Appoints Miles Harrison as President & Chief Executive Officer, to Shape the Future of True Tissue Regeneration | 243 | Newsfile | Reno, Nevada--(Newsfile Corp. - November 3, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a pre-commercial biotechnology company redefining regenerative medicine through next-generation... ► Artikel lesen | |
| 16.10.25 | Conexeu Sciences Inc.: Conexeu Sciences Closes Maximum $5M Reg CF Financing | 422 | Newsfile | Reno, Nevada--(Newsfile Corp. - October 16, 2025) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a biotechnology company revolutionizing tissue regeneration, is pleased to announce the completion... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 38,780 | -2,83 % | Ihre wichtigsten Termine: Allstate, Hensoldt, Atos, Richemont, Fresenius und Dürr stehen heute im Fokus! | © Foto: Britta Pedersen/zb/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,500 | -0,03 % | BARCLAYS stuft Siemens Healthineers auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Siemens Healthineers nach einer hauseigenen Management-Konferenz mit einem Kursziel von 50 Euro auf "Overweight"... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,260 | -3,89 % | Dividendenbekanntmachungen (22.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6712 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0645 EUR ADVANCED ENERGY INDUSTRIES... ► Artikel lesen | |
| QTREX QUANTUM | 0,715 | -1,64 % | Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity | RA'ANANA, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that, at the opening of trading on the Nasdaq... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,000 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,48 | -0,03 % | BMO raises BrightSpring Health stock price target on generic drug outlook | ||
| PROGYNY | 24,880 | 0,00 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| LIFESTANCE HEALTH GROUP | 7,390 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,330 | -0,12 % | Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity | ||
| PRIVIA HEALTH GROUP | 22,790 | 0,00 % | Privia Health Group, Inc. - 8-K, Current Report | ||
| GENEDX | 47,310 | 0,00 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| BILLIONTOONE | 85,92 | 0,00 % | Jim Cramer on BillionToOne: "I Say Buy It" | ||
| CO-DIAGNOSTICS | 5,075 | +0,10 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| BETA BIONICS | 11,820 | 0,00 % | Beta Bionics earmarks Q2 2027 for Mint patch pump launch, shares details on new tech | ||
| CARL ZEISS MEDITEC | 26,280 | +1,00 % | Carl Zeiss Meditec-Aktie: Sind das bereits gute Einstiegskurse? | Die Aktie des Medizintechnikunternehmens Carl Zeiss Meditec kommt weiterhin nicht zur Ruhe. Das schwache Marktumfeld und die zurückhaltende Investitionsbereitschaft vieler Kunden belasten das Geschäft... ► Artikel lesen |
Das Unternehmen CONEXEU SCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 14,900 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CONEXEU SCIENCES INC finden Sie auf Wallstreet Online.